Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Gunn

Showing results (111-120 of 216) with videos related to

Pageof 22
Sort By:
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|July 25, 2017
Quantification of human brain PDE4 occupancy by GSK356278: A [<sup>11</sup>C](R)-rolipram PET studyJasper van der Aart, Cristian Salinas, Rahul Dimber, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 4, 2019
Comparison of phosphodiesterase 10A and dopamine transporter levels as markers of disease burden in early Parkinson's diseaseGennaro Pagano, Flavia Niccolini, Heather Wilson, et al.
Translational Psychiatry|April 3, 2014
Effect of chronic antipsychotic treatment on striatal phosphodiesterase 10A levels: a [¹¹C]MP-10 PET rodent imaging study with ex vivo confirmationS Natesan, S Ashworth, J Nielsen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 2, 2016
Translocator positron-emission tomography and magnetic resonance spectroscopic imaging of brain glial cell activation in multiple sclerosisGourab Datta, Ines R Violante, Gregory Scott, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2010
Evaluation of 11C-GSK189254 as a novel radioligand for the H3 receptor in humans using PETSharon Ashworth, Eugenii A Rabiner, Roger N Gunn, et al.
Journal of the Neurological Sciences|August 20, 2016
Loss of extra-striatal phosphodiesterase 10A expression in early premanifest Huntington's disease gene carriersHeather Wilson, Flavia Niccolini, Salman Haider, et al.
Synapse (New York, N.Y.)|January 26, 2005
Behaviour of [11C]R(-)- and [11C]S(+)-rolipram in vitro and in vivo, and their use as PET radiotracers for the quantificative assay of PDE4Christine A Parker, Julian C Matthews, Roger N Gunn, et al.
Synapse (New York, N.Y.)|June 3, 2009
In vivo quantification of regional dopamine-D3 receptor binding potential of (+)-PHNO: Studies in non-human primates and transgenic miceEugenii A Rabiner, Mark Slifstein, Jose Nobrega, et al.
Brain : a Journal of Neurology|December 3, 1999
Huntington's disease progression. PET and clinical observationsT C Andrews, R A Weeks, N Turjanski, et al.
EJNMMI Research|May 27, 2017
Quantitative analysis of dynamic <sup>18</sup>F-FDG PET/CT for measurement of lung inflammationChristopher Coello, Marie Fisk, Divya Mohan, et al.
Pageof 22

Showing results (111-120 of 216) with videos related to

Sort By:
Pageof 22
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|July 25, 2017
Quantification of human brain PDE4 occupancy by GSK356278: A [<sup>11</sup>C](R)-rolipram PET studyJasper van der Aart, Cristian Salinas, Rahul Dimber, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 4, 2019
Comparison of phosphodiesterase 10A and dopamine transporter levels as markers of disease burden in early Parkinson's diseaseGennaro Pagano, Flavia Niccolini, Heather Wilson, et al.
Translational Psychiatry|April 3, 2014
Effect of chronic antipsychotic treatment on striatal phosphodiesterase 10A levels: a [¹¹C]MP-10 PET rodent imaging study with ex vivo confirmationS Natesan, S Ashworth, J Nielsen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 2, 2016
Translocator positron-emission tomography and magnetic resonance spectroscopic imaging of brain glial cell activation in multiple sclerosisGourab Datta, Ines R Violante, Gregory Scott, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2010
Evaluation of 11C-GSK189254 as a novel radioligand for the H3 receptor in humans using PETSharon Ashworth, Eugenii A Rabiner, Roger N Gunn, et al.
Journal of the Neurological Sciences|August 20, 2016
Loss of extra-striatal phosphodiesterase 10A expression in early premanifest Huntington's disease gene carriersHeather Wilson, Flavia Niccolini, Salman Haider, et al.
Synapse (New York, N.Y.)|January 26, 2005
Behaviour of [11C]R(-)- and [11C]S(+)-rolipram in vitro and in vivo, and their use as PET radiotracers for the quantificative assay of PDE4Christine A Parker, Julian C Matthews, Roger N Gunn, et al.
Synapse (New York, N.Y.)|June 3, 2009
In vivo quantification of regional dopamine-D3 receptor binding potential of (+)-PHNO: Studies in non-human primates and transgenic miceEugenii A Rabiner, Mark Slifstein, Jose Nobrega, et al.
Brain : a Journal of Neurology|December 3, 1999
Huntington's disease progression. PET and clinical observationsT C Andrews, R A Weeks, N Turjanski, et al.
EJNMMI Research|May 27, 2017
Quantitative analysis of dynamic <sup>18</sup>F-FDG PET/CT for measurement of lung inflammationChristopher Coello, Marie Fisk, Divya Mohan, et al.
Pageof 22